Search by Drug Name or NDC
NDC 62332-0601-25 Ketorolac Tromethamine 60 mg/2mL Details
Ketorolac Tromethamine 60 mg/2mL
Ketorolac Tromethamine is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is KETOROLAC TROMETHAMINE.
Product Information
| NDC | 62332-0601 |
|---|---|
| Product ID | 62332-601_84fec05c-9464-4148-a63c-05bfd6b88088 |
| Associated GPIs | |
| GCN Sequence Number | 031613 |
| GCN Sequence Number Description | ketorolac tromethamine VIAL 60 MG/2 ML INTRAMUSC |
| HIC3 | S2B |
| HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
| GCN | 35236 |
| HICL Sequence Number | 005175 |
| HICL Sequence Number Description | KETOROLAC TROMETHAMINE |
| Brand/Generic | Generic |
| Proprietary Name | Ketorolac Tromethamine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ketorolac Tromethamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 60 |
| Active Ingredient Units | mg/2mL |
| Substance Name | KETOROLAC TROMETHAMINE |
| Labeler Name | Alembic Pharmaceuticals Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214456 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62332-0601-25 (62332060125)
| NDC Package Code | 62332-601-25 |
|---|---|
| Billing NDC | 62332060125 |
| Package | 25 VIAL in 1 CARTON (62332-601-25) / 2 mL in 1 VIAL (62332-601-02) |
| Marketing Start Date | 2022-11-02 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.76863 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | KETOROLAC 60 MG/2 ML VIAL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis